Siwen Hu‐Lieskovan
University of Utah(US)Huntsman Cancer Institute(US)Utah Department of Health(US)University of Utah Health Care(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Immunotherapy and Immune Responses, Immune Cell Function and Interaction, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy(2017)5,288 cited
- → Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma(2016)3,493 cited
- → Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma(2016)3,099 cited
- → Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression(2017)1,859 cited
- → Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations(2016)1,263 cited
- → Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma(2023)765 cited